JM-6

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameJM-6
Drug Alias Namekynurenine 3-monooxygenase inhibitor (University of California Los Angeles/Gladstone Institute of Neurological Disease/University of Maryland)JM-6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKynurenine 3-monooxygenase inhibitors
TargetsKynurenine 3-monooxygenase
Therapy Area/IndicationsParkinson DiseaseNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California, Los Angeles
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGladstone Institute of Neurological DiseaseUM VenturesUniversity Of Maryland +[4] 
Active IndicationsN/A
Inactive IndicationsParkinson DiseaseNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A